Effect of trimetazidine on the functional capacity of ischemic heart disease patients not suitable for revascularization: meta-analysis of randomized controlled trials

HIGHLIGHTS

• who: Alyaa Ajabnoor and Amnah Mukhtar from the Faculty of Pharmacy, Department of Pharmacy Practice, King Abdulaziz University, Jeddah, Saudi Arabia have published the article: Effect of trimetazidine on the functional capacity of ischemic heart disease patients not suitable for revascularization: Meta-analysis of randomized controlled trials, in the Journal: PLOS ONE of November/28,/2021
• what: The overreaching aim of this systematic review is to investigate the effect of adding trimetazidine to first-line antianginal drugs on functional and exercise measurements in IHD patients not suitable for revascularization when compared to first-line antianginal . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.